The charts are meaningless for AMLN. This is a biotech company with 3 issues
which could move the stock. First is the FDA ruling on the label for Byetta.
Second is the potential approval for Byetta LAR. Last is the activist
shareholder Carl Icahn's play for the company. Icahn owns stock at around $20.

Long AMLN

If anyone knew for sure that AMLN or any stock were going up next week, they
would have unique powers that have never before been seen.

One can look at the bollinger bands, buying, support and resistance and position
themselves accordingly.

AMLN has certainly looked like its been in a volatility squeeze with an upward
bias. Not sure if it is strong enough to bypass a down market.

Believing anyone that tells you a stock will be up or down in a particular time
frame is never acceptable.

Look at the chart, read every bit of news about the stock and act responsibly,
maintaining tight stops because the market seems to be tightening its range with
a downward slant.